Vident Advisory, LLC Amicus Therapeutics, Inc. Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 108,879 shares of FOLD stock, worth $1.15 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
108,879
Previous 80,037
36.04%
Holding current value
$1.15 Million
Previous $943 Million
14.56%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding FOLD
# of Institutions
277Shares Held
324MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$303 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$297 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$290 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$258 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$224 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.97B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...